These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1406285)

  • 1. The class 1 outer membrane protein of Neisseria meningitidis produced in Bacillus subtilis can give rise to protective immunity.
    Nurminen M; Butcher S; Idänpään-Heikkilä I; Wahlström E; Muttilainen S; Runeberg-Nyman K; Sarvas M; Mäkelä PH
    Mol Microbiol; 1992 Sep; 6(17):2499-506. PubMed ID: 1406285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antibody response to a prototype liposome vaccine containing Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis.
    Idänpään-Heikkilä I; Muttilainen S; Wahlström E; Saarinen L; Leinonen M; Sarvas M; Mäkelä PH
    Vaccine; 1995 Nov; 13(16):1501-8. PubMed ID: 8578833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with meningococcal class 1 outer membrane protein produced in Bacillus subtilis and reconstituted in the presence of Zwittergent or Triton X-100.
    Idänpään-Heikkilä I; Wahlström E; Muttilainen S; Nurminen M; Käyhty H; Sarvas M; Mäkelä PH
    Vaccine; 1996 Jun; 14(9):886-91. PubMed ID: 8843630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis and reconstituted into phospholipid vesicles elicits antibodies to native P1 epitopes.
    Muttilainen S; Idänpään-Heikkilä I; Wahlström E; Nurminen M; Mäkelä PH; Sarvas M
    Microb Pathog; 1995 Jun; 18(6):423-36. PubMed ID: 8551945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to meningococcal class 1 outer-membrane protein and its variable regions in patients with systemic meningococcal disease.
    Idänpään-Heikkilä I; Høiby EA; Chattopadhyay P; Airaksinen U; Michaelsen TM; Wedege E
    J Med Microbiol; 1995 Nov; 43(5):335-43. PubMed ID: 7562997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with recombinant Opc outer membrane protein from Neisseria meningitidis: influence of sequence variation and levels of expression on the bactericidal immune response against meningococci.
    Jolley KA; Appleby L; Wright JC; Christodoulides M; Heckels JE
    Infect Immun; 2001 Jun; 69(6):3809-16. PubMed ID: 11349046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A linear B-cell epitope on the class 3 outer-membrane protein of Neisseria meningitidis recognized after vaccination with the Norwegian group B outer-membrane vesicle vaccine.
    Delvig AA; Wedege E; Caugant DA; Dalseg R; Kolberg J; Achtman M; Rosenqvist E
    Microbiology (Reading); 1995 Jul; 141 ( Pt 7)():1593-600. PubMed ID: 7551027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody production to a meningococcal outer membrane protein cloned into liv Salmonella typhimurium aroA vaccine strain.
    Tarkka E; Muotiala A; Karvonen M; Saukkonen-Laitinen K; Sarvas M
    Microb Pathog; 1989 May; 6(5):327-35. PubMed ID: 2505011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B:15:P1.16 in infant rat infection model: new prospects for vaccine development.
    Saukkonen K; Abdillahi H; Poolman JT; Leinonen M
    Microb Pathog; 1987 Oct; 3(4):261-7. PubMed ID: 3143885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with recombinant class 1 outer-membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococci.
    Christodoulides M; Brooks JL; Rattue E; Heckels JE
    Microbiology (Reading); 1998 Nov; 144 ( Pt 11)():3027-3037. PubMed ID: 9846738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with the recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis.
    Wright JC; Williams JN; Christodoulides M; Heckels JE
    Infect Immun; 2002 Aug; 70(8):4028-34. PubMed ID: 12117908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial.
    Wedege E; Høiby EA; Rosenqvist E; Bjune G
    Infect Immun; 1998 Jul; 66(7):3223-31. PubMed ID: 9632589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The infant rat model adapted to evaluate human sera for protective immunity to group B meningococci.
    Toropainen M; Käyhty H; Saarinen L; Rosenqvist E; Høiby EA; Wedege E; Michaelsen T; Mäkelä PH
    Vaccine; 1999 Jun; 17(20-21):2677-89. PubMed ID: 10418919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional activities and epitope specificity of human and murine antibodies against the class 4 outer membrane protein (Rmp) of Neisseria meningitidis.
    Rosenqvist E; Musacchio A; Aase A; Høiby EA; Namork E; Kolberg J; Wedege E; Delvig A; Dalseg R; Michaelsen TE; Tommassen J
    Infect Immun; 1999 Mar; 67(3):1267-76. PubMed ID: 10024570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with a multiple antigen peptide containing defined B- and T-cell epitopes: production of bactericidal antibodies against group B Neisseria meningitidis.
    Christodoulides M; Heckels JE
    Microbiology (Reading); 1994 Nov; 140 ( Pt 11)():2951-60. PubMed ID: 7529096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outer membrane protein (OMP) based vaccine for Neisseria meningitidis serogroup B.
    Pillai S; Howell A; Alexander K; Bentley BE; Jiang HQ; Ambrose K; Zhu D; Zlotnick G
    Vaccine; 2005 Mar; 23(17-18):2206-9. PubMed ID: 15755596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterologous production of the P1 porin of Neisseria meningitidis in bacillus subtilis: the effect of an N-terminal extension on the presentation of native-like epitopes.
    Muttilainen S; Butcher SJ; Runeberg K; Nurminen M; Idänpään-Heikkilä I; Wahlström E; Sarvas M
    Microb Pathog; 1995 May; 18(5):365-71. PubMed ID: 7476101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with synthetic peptides containing epitopes of the class 1 outer-membrane protein of Neisseria meningitidis: production of bactericidal antibodies on immunization with a cyclic peptide.
    Christodoulides M; McGuinness BT; Heckels JE
    J Gen Microbiol; 1993 Aug; 139(8):1729-38. PubMed ID: 7691983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with recombinant Chaperonin60 (Chp60) outer membrane protein induces a bactericidal antibody response against Neisseria meningitidis.
    Phillips R; Williams JN; Tan WM; Bielecka MK; Thompson H; Hung MC; Heckels JE; Christodoulides M
    Vaccine; 2013 May; 31(22):2584-90. PubMed ID: 23566947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection.
    Martin D; Cadieux N; Hamel J; Brodeur BR
    J Exp Med; 1997 Apr; 185(7):1173-83. PubMed ID: 9104804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.